ODCM
SAGE

Old Dominion Capital Management’s Sage Therapeutics SAGE Stock Holding History

Old Dominion Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,679
Closed -$338K – 147
2019
Q4 		$338K Sell
4,679
-9,561
-67% -$1.18M 0.11% 122
2019
Q3 		$2M Sell
14,240
-230
-2% -$38.5K 0.67% 47
2019
Q2 		$2.65M Sell
14,470
-50
-0.3% -$8.53K 0.92% 38
2019
Q1 		$2.43M Sell
14,520
-55
-0.4% -$7.96K 0.83% 42
2018
Q4 		$1.4M Buy
14,575
+3,245
+29% +$371K 0.5% 60
2018
Q3 		$1.6M Buy
+11,330
New +$1.75M 0.49% 59

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Old Dominion Capital Management's SAGE Position: Q1 2020 in Review

Old Dominion Capital Management sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 4,679 shares — an estimated $338K sold.

Old Dominion Capital Management first reported a position in SAGE in Q3 2018 and held it in 6 quarters. The position peaked at $2.65M in Q2 2019. 229 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

  • Old Dominion Capital Management reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Old Dominion Capital Management sold 4,679 Sage Therapeutics shares in Q1 2020, an estimated $338K.
  • Old Dominion Capital Management first reported a position in Sage Therapeutics in Q3 2018 and held it in 6 quarters.
  • Old Dominion Capital Management's Sage Therapeutics position peaked at $2.65M in Q2 2019.
  • 229 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on Old Dominion Capital Management's 13F filing for Q1 2020, filed 12 May 2020.